Red blood cells and platelets are anucleate blood components indispensable for oxygen delivery and hemostasis, respectively. Derivation of these blood elements from induced pluripotent stem (iPS) cells has the potential to develop blood donor-independent and genetic manipulation-prone products to complement or replace current transfusion banking, also minimizing the risk of alloimmunization. Wh...

Transfusions of blood products -both blood components and plasma derivativescan be life-saving procedures if used rationally Blood components/labile blood products/cells, plasma and cryo/ are provided by blood services and produced from single individual donations or pooled from several (up to 10-20) donations. Stable blood products/albumin, clotting factors, immunoglobulins , coagulation inhib...

introduction: blood derived products have been known as an effective treatment for many years. however, this treatment is not without risk of infections transmission including hepatitis b virus (hbv) and hepatitis c virus (hcv) and human immune-deficiency virus (hiv) in people who received the blood. nevertheless, due to a high risk of blood born diseases through blood transfusion, screening fo...

This paper provides a novel implementation of blockchain technology, and data is stored in decentralized distributed ledger to assist information protection blood supply chain management prevent loss or identity theft. The present used exclusively from the volunteers (known as donors), making its derivatives one significant roles treating diseases today. In particular, depending on type product...